Press briefings and stakeholder meetings
HumanCOVID-19
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Press briefings
EMA held press briefings to announce breaking news and explain its latest scientific work in tackling the COVID-19 pandemic:
- EMA regular press briefing on public health emergencies (06/06/2023)
- EMA regular press briefing on public health emergencies (15/02/2023)
- EMA regular press briefing on public health emergencies (16/12/2023)
- EMA regular press briefing on public health emergencies(24/11/2022)
- EMA regular press briefing on COVID-19 and monkeypox(26/10/2022)
- EMA regular press briefing on COVID-19 and monkeypox(20/09/2022)
- EMA regular press briefing on COVID-19 and monkeypox(02/09/2022)
- EMA regular press briefing on COVID-19(07/07/2022)
- EMA regular press briefing on COVID-19(02/06/2022)
- EMA regular press briefing on COVID-19(05/05/2022)
- EMA regular press briefing on COVID-19(17/03/2022)
- EMA regular press briefing on COVID-19(03/03/2022)
- EMA regular press briefing on COVID-19(17/02/2022)
- EMA regular press briefing on COVID-19(03/02/2022)
- EMA regular press briefing on COVID-19(18/01/2022)
- EMA regular press briefing on COVID-19(11/01/2022)
- EMA regular press briefing on COVID-19(21/12/2021)
- EMA regular press briefing on COVID-19(09/12/2021)
- EMA regular press briefing on COVID-19 (18/11/2021)
- EMA regular press briefing on COVID-19(04/11/2021)
- EMA regular press briefing on COVID-19(21/10/2021)
- EMA press briefing to inform on CHMP discussion on booster doses(05/10/2021)
- EMA regular press briefing on COVID-19(23/09/2021)
- EMA regular press briefing on COVID-19(09/09/2021)
- EMA regular press briefing on COVID-19(15/07/2021)
- EMA regular press briefing on COVID-19(01/07/2021)
- EMA regular press briefing on COVID-19(17/06/2021)
- EMA regular press briefing on COVID-19(28/05/2021)
- First EMA regular press briefing on COVID-19(12/05/2021)
- EMA press briefing to update on analysis of data on Vaxzevria, the COVID-19 vaccine from AstraZeneca(23/04/2021)
- Press briefing on PRAC conclusions on signal of thromboembolic events with COVID-19 Vaccine Janssen(20/04/2021)
- Press briefing on the conclusion of the assessment of the Pharmacovigilance Risk Assessment Committee (PRAC) of Vaxzevria (previously COVID-19 Vaccine AstraZeneca) and thromboembolic events(07/04/2021)
- Press briefing on the conclusion of the investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events by the Pharmacovigilance Risk Assessment Committee (PRAC)(18/03/2021)
- Press briefing on EU recommendation for COVID-19 Vaccine AstraZeneca(29/01/2021)
- Press briefing on EU recommendation on first COVID-19 vaccine(21/12/2020)
Public stakeholder meetings
EMA held public stakeholder meetings to discuss its work on the assessment, approval and safety monitoring of COVID-19 vaccines:
- Public stakeholder meeting on COVID-19 vaccines and therapeutics in the EU (25/11/2021)
- Public stakeholder meeting: approval, safety monitoring and impact of COVID-19 vaccines in the EU (26/03/2021)
- Public stakeholder meeting on the approval and roll-out of COVID-19 vaccines in the EU (08/01/2021)
- Public stakeholder meeting: development and authorisation of safe and effective COVID-19 vaccines in the EU (11/12/2020)